In 2009, the first glucagon and GLP-1 receptor co-agonist was reported, which combined action profiles of two gastrointestinal hormones within a single molecule achieving a synergistic glucose-lowering and weight loss benefit
Spagnoli LG, Orlandi A, Marino B, Mauriello A, De Angelis C, Ramacci MT
Unlike basic IV vitamin therapy, NAD infusions are slow, carefully monitored and highly individualized
And I'm so excited because I, you know, just launched as of this recording, my Avalon X digest, which that will, if you want to get, if you want to get enough protein in your eating window, that will really help you break it down, help you assimilate more protein
Dietary modifications significantly reduce gastrointestinal side effects